BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park J, Chang KJ, Seo YS, Byun BH, Choi JH, Moon H, Lim I, Kim BI, Choi CW, Lim SM. Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Nucl Med Mol Imaging 2014;48:295-302. [PMID: 26396634 DOI: 10.1007/s13139-014-0289-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Vinogradskiy Y, Diot Q, Jones B, Castillo R, Castillo E, Kwak J, Bowles D, Grills I, Myziuk N, Guerrero T, Stevens C, Schefter T, Gaspar LE, Kavanagh B, Miften M, Rusthoven C. Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer. Int J Radiat Oncol Biol Phys 2020;106:1063-70. [PMID: 31983558 DOI: 10.1016/j.ijrobp.2019.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim K, Kim IJ, Pak K, Kang T, Seol YM, Choi YJ, Kim H. Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative 18F-FDG PET-CT in breast cancer: a retrospective cross-sectional study. BMC Cancer 2021;21:1151. [PMID: 34706697 DOI: 10.1186/s12885-021-08886-2] [Reference Citation Analysis]
3 Deantonio L, Caroli A, Puta E, Ferrante D, Apicella F, Turri L, Sacchetti G, Brambilla M, Krengli M. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Radiat Oncol 2018;13:211. [PMID: 30359275 DOI: 10.1186/s13014-018-1154-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Schurink NW, Min LA, Berbee M, van Elmpt W, van Griethuysen JJM, Bakers FCH, Roberti S, van Kranen SR, Lahaye MJ, Maas M, Beets GL, Beets-tan RGH, Lambregts DMJ. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Eur Radiol 2020;30:2945-54. [DOI: 10.1007/s00330-019-06638-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Chong GO, Jeong SY, Lee YH, Park SH, Lee HJ, Lee SW, Hong DG, Lee YS. Improving the Prognostic Performance of SUVmax in 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Using Tumor-to-Liver and Tumor-to-Blood Standard Uptake Ratio for Locally Advanced Cervical Cancer Treated with Concurrent Chemoradiotherapy. J Clin Med 2020;9:E1878. [PMID: 32560143 DOI: 10.3390/jcm9061878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wu C, Cui Y, Zhao Y, Chen X, Liao X, Di L, Yin L, Liu M, Wang R. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative 18F-FDG PET/CT predicts poor prognosis of patients with clear cell renal cell carcinoma after nephrectomy. Eur J Radiol 2020;131:109218. [PMID: 32882538 DOI: 10.1016/j.ejrad.2020.109218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Tan H, Ma M, Huang J, Zhu W, Hu S, Zheng K, Rong P. Glucose Metabolism Reprogramming of Primary Tumor and the Liver Is Associated With Disease-Free Survival in Patients With Early NSCLC. Front Oncol 2021;11:752036. [PMID: 34778067 DOI: 10.3389/fonc.2021.752036] [Reference Citation Analysis]
8 Son SH, Kang SM, Jeong SY, Lee SW, Lee SJ, Lee J, Ahn BC. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Clin Nucl Med 2016;41:e266-73. [PMID: 27055144 DOI: 10.1097/RLU.0000000000001205] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pallavi M, Murali A, Periakaruppan G, Easwaramoorthy V, Mohanarangam VSP. Correlation between Reference Tissue Normalized 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Standardized Uptake Value Max of Nodal and Extranodal Sites in Lymphomas: An Empirical Study. Indian J Nucl Med 2021;36:371-6. [PMID: 35125754 DOI: 10.4103/ijnm.ijnm_74_21] [Reference Citation Analysis]
10 Shin S, Pak K, Kim IJ, Kim BS, Kim SJ. Prognostic Value of Tumor-to-Blood Standardized Uptake Ratio in Patients with Resectable Non-Small-Cell Lung Cancer. Nucl Med Mol Imaging 2017;51:233-9. [PMID: 28878849 DOI: 10.1007/s13139-016-0456-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
11 Li TC, Zhao X, Liu YN, Wang GL, Liu KF, Zhao K. Prognostic value of node-to-primary tumor maximum standardized uptake value ratio in T1-4N1-3M0 non-small cell lung cancer patients treated with concurrent chemo-radiotherapy. Nucl Med Commun 2022. [PMID: 35551163 DOI: 10.1097/MNM.0000000000001576] [Reference Citation Analysis]
12 Belge G, Bilgin C, Ozkaya G, Kandemirli SG, Alper E. Prognostic value of pretreatment tumor-to-blood standardized uptake ratio (SUR) in rectal cancer. Ann Nucl Med 2020;34:432-40. [PMID: 32297136 DOI: 10.1007/s12149-020-01465-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Wang C, Zhao K, Hu S, Huang Y, Ma L, Li M, Song Y. The PET-Derived Tumor-to-Liver Standard Uptake Ratio (SUV TLR ) Is Superior to Tumor SUVmax in Predicting Tumor Response and Survival After Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer. Front Oncol 2020;10:1630. [PMID: 33014819 DOI: 10.3389/fonc.2020.01630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Shi YM, Niu R, Shao XL, Zhang FF, Shao XN, Wang JF, Wang XS, Liu B, Yu WJ, Wang YT. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients. Nucl Med Commun 2020;41:459-68. [PMID: 32187163 DOI: 10.1097/MNM.0000000000001173] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Azmi NHM, Suppiah S, Liong CW, Noor NM, Said SM, Hanafi MH, Kaewput C, Saad FFA, Vinjamuri S. Reliability of standardized uptake value normalized to lean body mass using the liver as a reference organ, in contrast-enhanced 18F-FDG PET/CT imaging. Radiation Physics and Chemistry 2018;147:35-9. [DOI: 10.1016/j.radphyschem.2018.01.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
16 Jung JH, Son SH, Kim DH, Lee J, Jeong SY, Lee SW, Park HY, Lee J, Ahn BC. CONSORT-Independent prognostic value of asphericity of pretherapeutic F-18 FDG uptake by primary tumors in patients with breast cancer. Medicine (Baltimore) 2017;96:e8438. [PMID: 29145250 DOI: 10.1097/MD.0000000000008438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lee JH, Kang J, Baik SH, Lee KY, Lim BJ, Jeon TJ, Ryu YH, Sohn SK. Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level. Medicine (Baltimore). 2016;95:e2236. [PMID: 26735530 DOI: 10.1097/md.0000000000002236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
18 Huang J, Huang L, Zhou J, Duan Y, Zhang Z, Wang X, Huang P, Tan S, Hu P, Wang J, Huang M. Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection. Eur J Nucl Med Mol Imaging 2017;44:1958-68. [PMID: 28812134 DOI: 10.1007/s00259-017-3779-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
19 Osborne DR, Acuff SN, Fang M, Weaver MD, Fu Y. Assessing and reducing PET radiotracer infiltration rates: a single center experience in injection quality monitoring methods and quality improvement. BMC Med Imaging 2020;20:3. [PMID: 31924179 DOI: 10.1186/s12880-020-0408-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yin G, Song Y, Li X, Zhu L, Su Q, Dai D, Xu W. Prediction of mediastinal lymph node metastasis based on 18F-FDG PET/CT imaging using support vector machine in non-small cell lung cancer. Eur Radiol 2021;31:3983-92. [PMID: 33201286 DOI: 10.1007/s00330-020-07466-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ouyang ML, Tang K, Xu MM, Lin J, Li TC, Zheng XW. Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma. Clin Nucl Med 2018;43:715-20. [PMID: 30106864 DOI: 10.1097/RLU.0000000000002229] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Flood MP, Kong JC, Pham T, Waters PS, Soucisse M, Ramsay R, Wong H, Mitchell C, Michael M, Mccormick JJ, Warrier S, Akhurst T, Heriot A. Diagnostic performance of positron emission tomography in the staging of Pseudomyxoma peritonei. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.02.003] [Reference Citation Analysis]
23 Morio K, Kawaoka T, Aikata H, Namba M, Uchikawa S, Kodama K, Ohya K, Fujino H, Nakahara T, Murakami E, Yamauchi M, Tsuge M, Hiramatsu A, Imamura M, Nakamura Y, Akagi M, Awai K, Kobayashi T, Ohdan H, Chayama K. Preoperative PET-CT is useful for predicting recurrent extrahepatic metastasis of hepatocellular carcinoma after resection. Eur J Radiol. 2020;124:108828. [PMID: 31955034 DOI: 10.1016/j.ejrad.2020.108828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Komek H, Can C, Yilmaz U, Altindag S. Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer. Ann Nucl Med 2018;32:542-52. [PMID: 30006752 DOI: 10.1007/s12149-018-1277-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]